Lucane Pharma and Orpharma sign an exclusive distribution agreement concerning Pheburane for Australia and New Zealand.
First pre-NDA meeting with FDA concerning Pheburane for the USA.

Lucane Pharma is granted the EU Marketing Authorization for GranuPAS with an Orphan Drug status.
Kolbam gets the EU Marketing Authorization with an Orphan Drug status.

Lucane Pharma and Medical Need sign an exclusive distribution agreement concerning GranuPAS for the Baltics and some CEE countries.
Lucane Pharma and Metabolica sign an exclusive distribution agreement concerning Pheburane for Colombia.